Illumina, Inc.
(NASDAQ : ILMN)

( )
ILMN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 1.60%78.211.0%$1948.71m
AMGNAmgen, Inc. -1.66%205.411.3%$885.20m
REGNRegeneron Pharmaceuticals, Inc. -1.09%493.322.6%$821.01m
BIIBBiogen, Inc. -1.30%300.511.5%$730.72m
MRNAModerna, Inc. 4.94%34.840.0%$587.89m
VRTXVertex Pharmaceuticals, Inc. -1.59%238.311.9%$585.26m
ILMNIllumina, Inc. -3.48%263.503.5%$455.53m
ALXNAlexion Pharmaceuticals, Inc. -0.64%89.772.0%$278.42m
AAgilent Technologies, Inc. -2.63%70.391.6%$217.41m
INCYIncyte Corp. 1.97%78.592.5%$187.57m
EXASEXACT Sciences Corp. -3.21%55.7521.0%$173.77m
BMRNBioMarin Pharmaceutical, Inc. -2.15%84.214.3%$161.37m
SGENSeattle Genetics, Inc. -1.82%116.516.1%$157.34m
NVAXNovavax, Inc. 12.63%15.61114.7%$131.54m
SRPTSarepta Therapeutics, Inc. -2.46%93.6214.0%$100.23m

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.